Changes of hepatitis B virus serologic status after allogeneic hematopoietic stem cell transplantation and impact of donor immunity on hepatitis B virus

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 11, 2011, Pages 1630-1637

  Park, Silvia ^a   Kim, Kihyun ^a   Kim, Dong Hwan ^a   Jang, Jun Ho ^a   Kim, Seok Jin ^a   Kim, Won Seog ^a   Jung, Chul Won ^a   Koh, Kwang Cheol ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Allogeneic transplantation; Hepatitis B virus; Reverse seroconversion

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; RETROSPECTIVE STUDY; SEROCONVERSION; SOUTH KOREA; VIRUS IMMUNITY;

ADOLESCENT; ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 80054869146     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.04.006     Document Type: Article

References (32)

1. Leather H.L., Wingard J.R. Infections following hematopoietic stem cell transplantation. Infect Dis Clin North Am 2001, 15:483-520.
2. September 13-14, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 2003, 38:533-540. EASL International Consensus Conference on Hepatitis B.
3. Senecal D., Pichon E., Dubois F., Delain M., Linassier C., Colombat P. Acute hepatitis B after autologous stem cell transplantation in a man previously infected by hepatitis B virus. Bone Marrow Transplant 1999, 24:1243-1244.
4. Ma S.Y., Lau G.K., Cheng V.C., Liang R. Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation. Leuk Lymphoma 2003, 44:1281-1285.
5. Iwai K., Tashima M., Itoh M., et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplant 2000, 25:105-108.
6. Dhedin N., Douvin C., Kuentz M., et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 1998, 66:616-619.
7. Goyama S., Kanda Y., Nannya Y., et al. Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation. Leuk Lymphoma 2002, 43:2159-2163.
8. Seth P., Alrajhi A.A., Kagevi I., et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 2002, 30:189-194.
9. Knoll A., Boehm S., Hahn J., Holler E., Jilg W. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2004, 33:925-929.
10. Onozawa M., Hashino S., Izumiyama K., et al. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation 2005, 79:616-619.
11. Francisci D., Aversa F., Coricelli V., et al. Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. Haematologica 2006, 91:980-982.
12. Knoll A., Boehm S., Hahn J., Holler E., Jilg W. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepatol 2007, 14:478-483.
13. Lau G.K., Liang R., Chiu E.K., Lee C.K., Lam S.K. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 1997, 19:795-799.
14. Hui C.K., Lie A., Au W.Y., et al. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 2005, 106:464-469.
15. Ustun C., Koc H., Karayalcin S., et al. Hepatitis B virus infection in allogeneic bone marrow transplantation. Bone Marrow Transplant 1997, 20:289-296.
16. Martin B.A., Rowe J.M., Kouides P.A., DiPersio J.F. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplant 1995, 15:145-148.
17. Sakamaki H., Sato Y., Mori S.I., et al. Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation. Int J Hematol 2001, 74:342-346.
18. Kempinska A., Kwak E.J., Angel J.B. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis 2005, 41:1277-1282.
19. Lau G.K., Lok A.S., Liang R.H., et al. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 1997, 25:1497-1501.
20. Lau G.K., Suri D., Liang R., et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002, 122:614-624.
21. Lindemann M., Barsegian V., Runde V., et al. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. Transplantation 2003, 75:833-838.
22. Idilman R., Ustun C., Karayalcin S., et al. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation. Clin Transplant 2003, 17:438-443.
23. Kaloyannidis P., Batsis I., Yannaki E., et al. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer. Biol Blood Marrow Transplant 2007, 13:1049-1056.
24. Hammond S.P., Borchelt A.M., Ukomadu C., Ho V.T., Baden L.R., Marty F.M. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15:1049-1059.
25. Lee D.H., Kim J.H., Nam J.J., Kim H.R., Shin H.R. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002, 17:457-462.
26. Auletta J.J., Lazarus H.M. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 2005, 35:835-857.
27. Crooks G.M., Weinberg K., Mackall C. Immune reconstitution: from stem cells to lymphocytes. Biol Blood Marrow Transplant 2006, 12:42-46.
28. Onozawa M., Hashino S., Darmanin S., et al. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. Biol Blood Marrow Transplant 2008, 14:1226-1230.
29. Chen P.M., Fan S., Liu C.J., et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 1990, 49:708-713.
30. Ljungman P., Cordonnier C., Einsele H., et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009, 44:521-526.
31. Nordbo S.A., Skaug K., Holter E., Waage A., Brinch L. Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. Eur J Haematol 2000, 65:86-87.
32. Ljungman P., Lewensohn-Fuchs I., Hammarstrom V., et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994, 84:657-663.